<DOC>
	<DOCNO>NCT00687791</DOCNO>
	<brief_summary>The objective study determine safety effectiveness OculusGen™ ( ologen ) Biodegradable Collagen Matrix Implant hacotrabeculectomy surgery . The primary endpoint prove effectiveness via reduction IOP , secondary endpoint prove safety via incidence complication adverse event .</brief_summary>
	<brief_title>Oculusgen ( Ologen ) Collagen Matrix Implant Phaco-Trabeculectomy Primary Glaucoma : A Case-Control Study</brief_title>
	<detailed_description>Ologen™ Collagen Matrix indicate create mature bleb structure facilitate aqueous outflow reduction elevate intraocular pressure patient glaucoma , follow traditional filtering surgery ( trabeculectomy ) Within 60 day time implantation , ologen™ Collagen Matrix totally degrade . Postoperatively , mild inflammation may see anti- inflammatory agent prescribe</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<criteria>1 . Age 18 year . 2 . At least one eye diagnose glaucoma receive maximally tolerate medical therapy . 3 . Visually significant cataract visual acuity less equal 6/12 . 4 . Subject able willing cooperate investigation plan . 5 . Subject willing sign inform consent form . 1 . Known allergic reaction collagen . 2 . Subject Warfarin discontinuation recommend . 3 . Subject normal tension glaucoma aphakic glaucoma . 4 . Subject corneal disease . 5 . Participation investigational study 30 day proceed phacotrabeculectomy . 6 . Ocular infection within 14 day prior phacotrabeculectomy . 7 . Pregnant breastfeed woman . 8 . Monocular subject .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>patient cataract glaucoma</keyword>
	<keyword>ologen</keyword>
	<keyword>oculusgen</keyword>
	<keyword>collagen matrix</keyword>
	<keyword>Phacotrabeculectomy</keyword>
	<keyword>Aeon Astron</keyword>
	<keyword>trabeculectomy</keyword>
	<keyword>tissue engineering</keyword>
	<keyword>mitomycin-C</keyword>
</DOC>